Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tom’s Of Maine Original Formula’s Use As Reference Standard Urged

This article was originally published in The Tan Sheet

Executive Summary

Tom's of Maine intends to market new dentifrice products formulated with sodium monofluoro-phosphate in a calcium-only abrasive system pending reference standard testing for fluoride bioavailability, according to the Kennebunk, Maine company

You may also be interested in...

Tom's of Maine non-animal test shows original toothpaste formula effectiveness, FDA says.

TOM'S OF MAINE DENTIFRICE FORMULATIONS MUST BE INDIVIDUALLY TESTED for effectiveness, FDA told the Kennebunk, Maine-based company in a recent letter. Tom's had asked the agency in a Feb. 16 citizen petition to accept data from an intra-oral remineralization test in humans using the original Tom's Natural Toothpaste formula to show bioavailability of the fluoride ion in all of its fluoride toothpastes ("The Tan Sheet" March 4, p. 5). The company's corporate philosophy of not testing its products in animals conflicts with the OTC anticaries final monograph requirement that bioavailability be demonstrated through animal testing. Tom's is proceeding with testing its other toothpaste formulas.

Fluoride bioavailability in toothpastes: alternative test method proposed by Tom's of Maine.

ANTICARIES FLUORIDE BIOAVAILABILITY ALTERNATIVE TESTING PROCEDURE PROPOSED by Tom's of Maine to meet biological test requirements for fluoride dentifrice drug products in the OTC anticaries final monograph. In a Feb. 16 citizen petition, the natural toothpaste marketer asked that FDA accept data from an "intra-oral remineralization test in human subjects" as a replacement for the animal caries reduction test specified in the monograph.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts